XML 50 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Options and Equity Estimated Based on Weighted Average Assumptions

Schedule of Options and Equity Estimated Based on Weighted Average Assumptions

   Year Ended December 31, 
   2024   2023 
Risk-free interest rate       4.37%
Expected dividend yield        
Expected life       10 years 
Expected volatility       99.91%
Weighted average grant date fair value for options issued       $0.43 per option for 400,000 options 
Schedule of Unvested Stock Option Activity

Unvested stock option activity for non-employees:

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested December 31, 2022   166,789   $4.05    9.49     
Granted   360,000    0.46    10.18     
Vested   (137,565)   0.47    9.47     
 Expired   (776)   145.24         
Forfeited   (53,447)   1.31         
Unvested December 31, 2023   335,001   $1.83    10.70     
Granted                
Vested   (334,906)   0.46    10.18     
 Expired   (95)            
Forfeited                
Unvested December 31, 2024                
Schedule of Warrants Outstanding and Exercisable

Information regarding warrants outstanding and exercisable into shares of common stock is summarized below:

 

   2024   2023 
   Shares   Warrant
Price
   Weighted
Average
Exercise
Price
   Shares   Warrant
Price
   Weighted
Average
Exercise
Price
 
Outstanding, beginning of year   152,160   $0.99-8.80   $8.03    226,610   $0.99-132.00   $9.10 
Granted   20,587,988    0.28-0.363    0.33             
Expired   (147,501)   0.99-8.80    8.03    (74,450)   17.05    17.05 
Exercised   (4,659)   8.80    8.80             
Outstanding, end of year  20,587,988   $ 0.28-0.363   $0.33    152,160    $ 0.99-8.80   $8.03 
Exercisable   11,281,916   $0.363   $0.363    152,160    $ 0.99-8.80   $8.03 
Weighted average remaining contractual life   3.75 years              .75 years           
Years exercisable   2025              2024           
Share-Based Payment Arrangement, Employee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Vested Stock Option Activity

Vested stock option activity for employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding December 31, 2022   2,020,214   $3.01    8.86     
Granted   400,000    0.47    10.17     
Forfeited   (7,601)   9.68         
Expired   (4,175)   41.61         
Outstanding December 31, 2023   2,408,438   $2.50    8.70     
Granted                
Forfeited                 
Expired   (806)            
Outstanding December 31, 2024   2,407,632   $2.42    8.70     
Vested and expected to vest at December 31, 2024   2,407,632   $2.42    8.70     
Exercisable at December 31, 2024   2,407,632   $1.61    7.26     
Schedule of Unvested Stock Option Activity

Unvested stock option activity for employees:

   Number of
Options
   Weighted
Average
Exercise
Price
   Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Unvested December 31, 2022   392,326   $0.80    8.86     
Granted   400,000    0.47    10.17     
Vested   (413,884)   1.90    6.73     
Forfeited   (7,601)   9.68         
Expired   (4,175)   41.61         
Unvested December 31, 2023   366,666   $2.13    12.44     
Granted                
Vested   (365,860)   0.47    7.26     
Forfeited                
Expired   (806)            
Unvested December 31, 2024      $         
Share-Based Payment Arrangement, Nonemployee [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Vested Stock Option Activity

Vested stock option activity for non-employees:

 

   Number
of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contracted
Term
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding December 31, 2022   579,155   $3.09    8.36     
Granted   360,000    0.46    10.04     
Expired   (653)   145.24         
Forfeited   (53,447)   1.31         
Outstanding December 31, 2023   885,055   $2.02    9.23     
Granted                
Exercised                
 Expired   (95)            
Forfeited                
Outstanding December 31, 2024   884,960   $1.88    9.23     
Vested and expected to vest at December 31, 2024   884,960   $1.88    9.23     
Exercisable at December 31, 2024   884,960   $1.62    9.51     
Equity Incentive Plan Two Thousand Nine [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

Information regarding the options approved by the Board of Directors under the Equity Plan of 2009 is summarized below. The plan expired on June 24, 2019:

 

   2024   2023 
   Shares   Option
Price
   Weighted
Average
Exercise
Price
   Shares   Option
Price
   Weighted
Average
Exercise
Price
 
Outstanding, beginning of year   119,352   $13.20-2,127.84   $20.72    124,399   $13.201,003.20   $22.23 
Granted                        
Forfeited               (5,047)   9.68-327.36    57.79 
Expired   (901)   190   $356.36             
Outstanding, end of year   118,451   $13.20-2,127.84   $18.17    119,352   $13.20-2,127.84   $20.72 
Exercisable, end of year   118,451   $13.20-2,127.84   $

18.17

    119,352   $13.20-2,127.84      
Weighted average remaining contractual life (years)
   3.08 years              4.06 years           
Equity Incentive Plans Two Thousand And Eighteen [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

 

Information regarding the options approved by the Board of Directors under the Equity Plan of 2018 is summarized below:

 

   2024   2023 
   Shares   Option
Price
   Weighted
Average
Exercise
Price
   Shares   Option
Price
   Weighted
Average
Exercise
Price
 
Outstanding, beginning of year   2,814,142   $0.31-9.68   $1.54    2,474,971   $0.31-9.68   $1.72 
Granted               400,000    0.47-0.47    0.47 
Forfeited               (60,829)   0.31-9.68    1.98 
Outstanding, end of year   2,814,142   $0.31-9.68   $1.54    2,814,142   $0.31-9.68   $1.54 
Exercisable, end of year   2,814,142   $0.31-9.68   $

1.54

    2,397,474   $0.31-327.36    4.71 
Weighted average remaining contractual life (years)   6.96 years              7.96 years           
Available for future grants   487,050              1,210,286           
Equity Incentive Plan 2018 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

Information regarding the options approved by the Board of Directors under the Equity Plan of 2018 is summarized below:

 

   2024   2023 
   Shares   Option
Price
   Weighted
Average
Exercise
Price
   Shares   Option
Price
   Weighted
Average
Exercise
Price
 
Outstanding, beginning of year   2,814,142   $0.31-9.68   $1.54    2,474,971   $0.31-9.68   $1.72 
Granted               400,000    0.47-0.47    0.47 
Forfeited               (60,829)   0.31-9.68    1.98 
Outstanding, end of year   2,814,142   $0.31-9.68   $1.54    2,814,142   $0.31-9.68   $1.54 
Exercisable, end of year   2,814,142   $0.31-9.68   $

1.54

    2,397,474   $0.31-327.36    4.71 
Weighted average remaining contractual life (years)   6.96 years              7.96 years           
Available for future grants   487,050              1,210,286